SEBI Registration NO.---- INA000001530 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS or messenger.

Top Stocks to be Focused for 31 March 2017

Top Stocks to be Focused for 31 March 2017

Zensar Technologies: The company said it would buy Keystone Logic for about Rs 132 crore as it looks to build its digital commerce capabilities. The IT firm’s chairman said more acquisitions were on the horizon.

NTPC: The company on Thursday informed bourses that 60 MW capacity (4×65 mw) of Bhadla Solar PV Project at Bhadla Rajasthan, is declared on Commercial Operation w.e.f. 00:00 hrs. Of 25.03.2017.

Power Grid Corporation Of India Ltd: The company on Thursday approved investments worth Rs 429 crore.

Mukand Ltd: Specialty steel maker Mukand Ltd and Sumitomo Corp of Japan have signed an agreement to form a joint venture that will set up a rolling mill in Karnataka.

Jindal Steel BSE 3.41 % and Power: Debt-ridden Jindal Steel and Power LtdBSE 3.41 % (JSPL) on Thursday said its board has approved issuance of 4.8 crore convertible warrants to Opelina and Investment Ltd, a promoter group entity, on preferential basis.

L&T: Larsen & Toubro (L&T) announced on Thursday that it has won new orders worth Rs 4,000 crore from the hydro carbon sector.

Bharti Infratel, Idea Cellular: With two deep-pocket investors KKR and Canada Pension Plan Investment Board (CPPIB) on board, Bharti Infratel is eyeing Vodafone Plc’s 42 per cent stake in Indus Towers -their three-way joint venture with Idea CellularBSE -0.69 %, said two people familiar with the development. This could be followed by Idea divesting its stake to Infratel as well.

Vedanta: Anil Agarwal’s flagship company Vedanta on Thursday approved a second interim dividend of Rs 17.7 a share for FY17, following the example of record payouts by group company Hindustan Zinc.

State Bank of India (SBI): The State Bank of India has raised $500 million by selling bonds to overseas investors seeking to tap cheaper money before US Federal Reserve increases the rate adding to the borrowing costs globally.

Sun Pharma BSE -0.17 %, Cadila Healthcare: Sun Pharma and Cadila HealthcareBSE 0.11 % are recalling one product each from the US market due to contamination and presence of “foreign” tablets respectively. While Sun Pharmaceutical Industries Inc is recalling 83,188 single dose vials of Testosterone Cypionate injection, ZydusBSE -0.20 % Pharmaceuticals USA Inc is recalling 9,561 bottles Atenolol tablets.

2
 
error: Content is protected !!